ConductScience.org, home

Paper36137752

Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.

Morath C and 32 others. J Am Soc Nephrol, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients. Papers, record 36137752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36137752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
PubMed
Journal
J Am Soc Nephrol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.31
iCite
Revised in PubMed
2026-07-03
PubMed

Authors33

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morath CChristian
2Schaier MMatthias
3Ibrahim EEman
4Wang LLei
5Kleist CChristian
6Opelz GGerhard
7Süsal CCaner
8Ponath GGerald
9Aly MMostafa
10Alvarez CMCristiam M
11Kälble FFlorian
12Speer CClaudius
13Benning LLouisehttps://orcid.org/0000-0002-8366-2100
14Nusshag CChristian
15Pego da Silva LLuiza
16Sommerer CClaudia
17Hückelhoven-Krauss AAngela
18Czock DDavid
19Mehrabi AArianeb
20Schwab CConstantin

Source PubMed

See all 33 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Kidney TransplantationMajor topic
B-Lymphocytes, RegulatoryMajor topic
Humans
Immunosuppressive Agents
Immunosuppression Therapy
Immune Tolerance
Transplant Recipients

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02560220MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant RecipientsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36719144Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action.https://conductscience.org/library/papers/36719144

Source PubMed

Download CSV of comments and corrections

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41283510Influence and Role of Regulatory B Cells in Organ Transplantation: The State of the Art, Prospects, and Emerging Insights.Antibodies (Basel)2025https://conductscience.org/library/papers/41283510PubMed
41210169Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/41210169PubMed
41007627Anti-B Cell Strategy in Nephrotic Syndrome: Beyond Rituximab.Biomedicines2025https://conductscience.org/library/papers/41007627PubMed
40264774Regulatory B cells, the key regulator to induce immune tolerance in organ transplantation.Front Immunol2025https://conductscience.org/library/papers/40264774PubMed
40035907Frontiers and Controversies in De Novo Gastrointestinal Tumors After Organ Transplantation: Current Progress and Future Directions.Ann Surg Oncol2025https://conductscience.org/library/papers/40035907PubMed
38393856The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance.Clin Exp Immunol2024https://conductscience.org/library/papers/38393856PubMed
37483623Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.Front Immunol2023https://conductscience.org/library/papers/37483623PubMed
36368749
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
BMJ Open2022https://conductscience.org/library/papers/36368749PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD24100133941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36137752

GET https://conductscience.org/api/papers/v1/36137752/authors?page=2